266 related articles for article (PubMed ID: 36387232)
1. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
Stefani A; Piro G; Schietroma F; Strusi A; Vita E; Fiorani S; Barone D; Monaca F; Sparagna I; Valente G; Ferrara MG; D'Argento E; Di Salvatore M; Carbone C; Tortora G; Bria E
Front Oncol; 2022; 12():1026020. PubMed ID: 36387232
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinases in ovarian cancer.
Pérez-Fidalgo JA; Gambardella V; Pineda B; Burgues O; Piñero O; Cervantes A
ESMO Open; 2020 Oct; 5(5):e000718. PubMed ID: 33087400
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
Krushkal J; Silvers T; Reinhold WC; Sonkin D; Vural S; Connelly J; Varma S; Meltzer PS; Kunkel M; Rapisarda A; Evans D; Pommier Y; Teicher BA
Clin Epigenetics; 2020 Jun; 12(1):93. PubMed ID: 32586373
[TBL] [Abstract][Full Text] [Related]
4. Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer.
Sankhe K; Prabhu A; Khan T
Chem Biol Drug Des; 2021 Jul; 98(1):73-93. PubMed ID: 33934503
[TBL] [Abstract][Full Text] [Related]
5. A framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Sos ML; Dietlein F; Peifer M; Schöttle J; Balke-Want H; Müller C; Koker M; Richters A; Heynck S; Malchers F; Heuckmann JM; Seidel D; Eyers PA; Ullrich RT; Antonchick AP; Vintonyak VV; Schneider PM; Ninomiya T; Waldmann H; Büttner R; Rauh D; Heukamp LC; Thomas RK
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17034-9. PubMed ID: 23035247
[TBL] [Abstract][Full Text] [Related]
6. Regulation of spindle and chromatin dynamics during early and late stages of oocyte maturation by aurora kinases.
Swain JE; Ding J; Wu J; Smith GD
Mol Hum Reprod; 2008 May; 14(5):291-9. PubMed ID: 18353803
[TBL] [Abstract][Full Text] [Related]
7. Identification of polypharmacological anticancerous molecules against Aurora kinase family of proteins.
Gupta D; Kumar M; Singh M; Salman M; Das U; Kaur P
J Cell Biochem; 2022 Apr; 123(4):719-735. PubMed ID: 35040172
[TBL] [Abstract][Full Text] [Related]
8. The Aurora kinase inhibitors in cancer research and therapy.
Cicenas J
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1995-2012. PubMed ID: 26932147
[TBL] [Abstract][Full Text] [Related]
9. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
Kaestner P; Stolz A; Bastians H
Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
[TBL] [Abstract][Full Text] [Related]
10. Targeting aurora kinases in cancer treatment.
Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
[TBL] [Abstract][Full Text] [Related]
11. Influence of different pH milieu on the structure and function of human Aurora kinase B protein (AURK-B): Amalgamation of both spectroscopic and computational approach.
Gupta D; Kumari R; Kumar M; Singh M; Rawat S; Ethayathulla AS; Kaur P
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 312():124047. PubMed ID: 38394881
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors.
Jadhav M; Sankhe K; Bhandare RR; Edis Z; Bloukh SH; Khan TA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500603
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase inhibitors in preclinical and clinical testing.
Cheung CH; Coumar MS; Hsieh HP; Chang JY
Expert Opin Investig Drugs; 2009 Apr; 18(4):379-98. PubMed ID: 19335272
[TBL] [Abstract][Full Text] [Related]
15. The role of Aurora-A inhibitors in cancer therapy.
Agnese V; Bazan V; Fiorentino FP; Fanale D; Badalamenti G; Colucci G; Adamo V; Santini D; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi47-52. PubMed ID: 17591831
[TBL] [Abstract][Full Text] [Related]
16. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinases: structure, functions and their association with cancer.
Kollareddy M; Dzubak P; Zheleva D; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):27-33. PubMed ID: 18795071
[TBL] [Abstract][Full Text] [Related]
18. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
[TBL] [Abstract][Full Text] [Related]
19. Advances in Aurora kinase inhibitor patents.
Coumar MS; Cheung CH; Chang JY; Hsieh HP
Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase inhibitors: progress towards the clinic.
Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M
Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
